Выпуск
Pharmaceutical Executive Daily: FDA Approves Voceryq
Pharmaceutical Executive · 2 ноября 2026 г. · 2 мин
FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of digital clone use cases in pharma, and CytoDyn’s Dr. Jay Lalezari on his path from HIV clinician to CEO.